MetLife Investment Management’s Medicines Co MDCO Stock Holding History

MetLife Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-31,880	Closed	-$2.71M	–	2368
2019 Q4	$2.71M	Sell	31,880 -1,155	-3%	-$77K	0.03%	679
2019 Q3	$1.65M	Buy	33,035 +997	+3%	+$39.8K	0.02%	859
2019 Q2	$1.17M	Hold	32,038	–	–	0.01%	1036
2019 Q1	$895K	Hold	32,038	–	–	0.01%	1127
2018 Q4	$613K	Hold	32,038	–	–	0.01%	1242
2018 Q3	$958K	Hold	32,038	–	–	0.01%	1146
2018 Q2	$1.18M	Hold	32,038	–	–	0.01%	961
2018 Q1	$1.05M	Hold	32,038	–	–	0.01%	987
2017 Q4	$876K	Buy	+32,038	New	+$987K	0.01%	1086

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

MetLife Investment Management's MDCO Position: Q1 2020 in Review

MetLife Investment Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 31,880 shares — an estimated $2.71M sold.

MetLife Investment Management first reported a position in MDCO in Q4 2017 and held it in 9 quarters. The position peaked at $2.71M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

MetLife Investment Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
MetLife Investment Management sold 31,880 Medicines Co shares in Q1 2020, an estimated $2.71M.
MetLife Investment Management first reported a position in Medicines Co in Q4 2017 and held it in 9 quarters.
MetLife Investment Management's Medicines Co position peaked at $2.71M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on MetLife Investment Management's 13F filing for Q1 2020, filed 15 May 2020.